Sandy Donaldson discusses how pharma companies are developing precise marketing strategies for the modern world.
Sandy Donaldson
Advertisement
Sandy Donaldson is a co-founder and chief strategy officer at Impiricus.
Articles by Sandy Donaldson
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Gilead Sciences Enters $7.8 Billion Definitive Agreement to Acquire Arcellx
2
Merck’s Oncology Spin-Out: Organizational Design as Patent Cliff Strategy
3
The Emergence of Cancer Vaccines: Reframing Value Demonstration, Pricing, and Access
4
How FDA's Action Against Non-FDA-Approved GLP-1 Products Affects the Competitive Landscape
5